Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-Oncology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Market Perspective (2017-2028)
2.2 Immuno-Oncology Growth Trends by Region
2.2.1 Immuno-Oncology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immuno-Oncology Historic Market Size by Region (2017-2022)
2.2.3 Immuno-Oncology Forecasted Market Size by Region (2023-2028)
2.3 Immuno-Oncology Market Dynamics
2.3.1 Immuno-Oncology Industry Trends
2.3.2 Immuno-Oncology Market Drivers
2.3.3 Immuno-Oncology Market Challenges
2.3.4 Immuno-Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Players by Revenue
3.1.1 Global Top Immuno-Oncology Players by Revenue (2017-2022)
3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2017-2022)
3.2 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Revenue
3.4 Global Immuno-Oncology Market Concentration Ratio
3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2021
3.5 Immuno-Oncology Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Breakdown Data by Type
4.1 Global Immuno-Oncology Historic Market Size by Type (2017-2022)
4.2 Global Immuno-Oncology Forecasted Market Size by Type (2023-2028)
5 Immuno-Oncology Breakdown Data by Application
5.1 Global Immuno-Oncology Historic Market Size by Application (2017-2022)
5.2 Global Immuno-Oncology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immuno-Oncology Market Size (2017-2028)
6.2 North America Immuno-Oncology Market Size by Type
6.2.1 North America Immuno-Oncology Market Size by Type (2017-2022)
6.2.2 North America Immuno-Oncology Market Size by Type (2023-2028)
6.2.3 North America Immuno-Oncology Market Share by Type (2017-2028)
6.3 North America Immuno-Oncology Market Size by Application
6.3.1 North America Immuno-Oncology Market Size by Application (2017-2022)
6.3.2 North America Immuno-Oncology Market Size by Application (2023-2028)
6.3.3 North America Immuno-Oncology Market Share by Application (2017-2028)
6.4 North America Immuno-Oncology Market Size by Country
6.4.1 North America Immuno-Oncology Market Size by Country (2017-2022)
6.4.2 North America Immuno-Oncology Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Immuno-Oncology Market Size (2017-2028)
7.2 Europe Immuno-Oncology Market Size by Type
7.2.1 Europe Immuno-Oncology Market Size by Type (2017-2022)
7.2.2 Europe Immuno-Oncology Market Size by Type (2023-2028)
7.2.3 Europe Immuno-Oncology Market Share by Type (2017-2028)
7.3 Europe Immuno-Oncology Market Size by Application
7.3.1 Europe Immuno-Oncology Market Size by Application (2017-2022)
7.3.2 Europe Immuno-Oncology Market Size by Application (2023-2028)
7.3.3 Europe Immuno-Oncology Market Share by Application (2017-2028)
7.4 Europe Immuno-Oncology Market Size by Country
7.4.1 Europe Immuno-Oncology Market Size by Country (2017-2022)
7.4.2 Europe Immuno-Oncology Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Market Size (2017-2028)
8.2 Asia-Pacific Immuno-Oncology Market Size by Type
8.2.1 Asia-Pacific Immuno-Oncology Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Immuno-Oncology Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Immuno-Oncology Market Share by Type (2017-2028)
8.3 Asia-Pacific Immuno-Oncology Market Size by Application
8.3.1 Asia-Pacific Immuno-Oncology Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Immuno-Oncology Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Immuno-Oncology Market Share by Application (2017-2028)
8.4 Asia-Pacific Immuno-Oncology Market Size by Region
8.4.1 Asia-Pacific Immuno-Oncology Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Immuno-Oncology Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Market Size (2017-2028)
9.2 Latin America Immuno-Oncology Market Size by Type
9.2.1 Latin America Immuno-Oncology Market Size by Type (2017-2022)
9.2.2 Latin America Immuno-Oncology Market Size by Type (2023-2028)
9.2.3 Latin America Immuno-Oncology Market Share by Type (2017-2028)
9.3 Latin America Immuno-Oncology Market Size by Application
9.3.1 Latin America Immuno-Oncology Market Size by Application (2017-2022)
9.3.2 Latin America Immuno-Oncology Market Size by Application (2023-2028)
9.3.3 Latin America Immuno-Oncology Market Share by Application (2017-2028)
9.4 Latin America Immuno-Oncology Market Size by Country
9.4.1 Latin America Immuno-Oncology Market Size by Country (2017-2022)
9.4.2 Latin America Immuno-Oncology Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Market Size (2017-2028)
10.2 Middle East & Africa Immuno-Oncology Market Size by Type
10.2.1 Middle East & Africa Immuno-Oncology Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Immuno-Oncology Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Immuno-Oncology Market Share by Type (2017-2028)
10.3 Middle East & Africa Immuno-Oncology Market Size by Application
10.3.1 Middle East & Africa Immuno-Oncology Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Immuno-Oncology Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Immuno-Oncology Market Share by Application (2017-2028)
10.4 Middle East & Africa Immuno-Oncology Market Size by Country
10.4.1 Middle East & Africa Immuno-Oncology Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Immuno-Oncology Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2017-2022)
11.1.5 Bristol-Myers Squibb Recent Developments
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2017-2022)
11.2.5 Merck & Co., Inc. Recent Developments
11.3 Roche AG
11.3.1 Roche AG Company Details
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Immuno-Oncology Introduction
11.3.4 Roche AG Revenue in Immuno-Oncology Business (2017-2022)
11.3.5 Roche AG Recent Developments
11.4 AstraZeneca, Plc
11.4.1 AstraZeneca, Plc Company Details
11.4.2 AstraZeneca, Plc Business Overview
11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2017-2022)
11.4.5 AstraZeneca, Plc Recent Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Immuno-Oncology Introduction
11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2017-2022)
11.5.5 Sanofi S.A. Recent Developments
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Details
11.6.2 Dendreon Pharmaceuticals Business Overview
11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2017-2022)
11.6.5 Dendreon Pharmaceuticals Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Immuno-Oncology Introduction
11.7.4 Novartis Revenue in Immuno-Oncology Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Details
11.8.2 Gilead Sciences Inc. Business Overview
11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2017-2022)
11.8.5 Gilead Sciences Inc. Recent Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Immuno-Oncology Introduction
11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2017-2022)
11.9.5 Merck KGaA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer